Aclarion (ACON) News Today $5.11 -0.16 (-3.04%) Closing price 04:00 PM EasternExtended Trading$4.74 -0.37 (-7.26%) As of 06:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Aclarion, Inc. (ACON) to Showcase NOCISCAN’s Impact on Spine Surgery at 2025 Spine SummitFebruary 20 at 4:37 PM | msn.comAclarion to Showcase Groundbreaking NOCISCAN Technology at the 2025 Spine SummitFebruary 20 at 6:00 AM | globenewswire.comAclarion Wins Patent, Shares Eke UpFebruary 11, 2025 | baystreet.caAclarion receives U.S. patent on expanded applications of MRS data processingFebruary 11, 2025 | markets.businessinsider.comAclarion Receives US Patent to Protect Expanded Applications of Magnetic Resonance Spectroscopy (MRS) Data Processing to Identify Pain and Infection Biomarkers Throughout the BodyFebruary 11, 2025 | globenewswire.comAclarion Announces Northwestern Medicine as First CLARITY Trial SiteFebruary 6, 2025 | globenewswire.comAclarion secures funding for pivotal CLARITY trialFebruary 4, 2025 | msn.comAclarion announces CLARITY trial for Nociscan fully fundedFebruary 4, 2025 | markets.businessinsider.com1ACON : What's Going On With Aclarion Stock Tuesday?February 4, 2025 | benzinga.comAclarion Announces CLARITY Trial for Nociscan Now Fully FundedFebruary 4, 2025 | globenewswire.comNOCISCAN touted as lumbar pain diagnostic advanceFebruary 1, 2025 | msn.comAclarion to Showcase Groundbreaking NOCISCAN Technology at the Selby Spine ConferenceJanuary 31, 2025 | globenewswire.comAclarion Inc trading halted, volatility trading pauseJanuary 31, 2025 | markets.businessinsider.comAclarion announces reverse stock split effective January 29January 31, 2025 | msn.comAclarion Inc trading halted, news pendingJanuary 30, 2025 | markets.businessinsider.comAclarion Announces Closing of $14.4 Million Public Offering of Common Stock and WarrantsJanuary 17, 2025 | finance.yahoo.comEQS-News: Aclarion Announces Closing of $14.4 Million Public Offering of Common Stock and WarrantsJanuary 17, 2025 | markets.businessinsider.comAclarion Announces Pricing of $14.4 Million Public Offering of Common Stock and WarrantsJanuary 15, 2025 | finance.yahoo.comEQS-News: Aclarion Announces Pricing of Registered Direct Offering of Common Stock Priced at the MarketJanuary 4, 2025 | markets.businessinsider.comMaxim Group Downgrades Aclarion (ACON)December 14, 2024 | msn.comAclarion announces Nociscan featured RSNA Edition of MAGNETOM FlashNovember 21, 2024 | markets.businessinsider.comAclarion Announces Nociscan Featured in RSNA Edition of Siemens MAGNETOM FlashNovember 21, 2024 | globenewswire.comAclarion files to sell 27.52M shares of common stock for holdersNovember 5, 2024 | markets.businessinsider.comAclarion files to sell 20M shares of common stock for holdersOctober 25, 2024 | markets.businessinsider.comAclarion to Participate in the 2024 Maxim Healthcare Virtual SummitOctober 10, 2024 | globenewswire.comAclarion’s Nociscan Technology Enhances Understanding of Modic Changes in Back Pain PatientsSeptember 30, 2024 | msn.comAclarion's Nociscan AI Plays Key Role in Advanced Understanding of Modic ChangesSeptember 27, 2024 | globenewswire.comPRISM MarketView Showcases Aclarion: Disrupting Chronic Pain Treatment with Nociscan AI TechnologySeptember 13, 2024 | globenewswire.comAclarion, Inc.: Aclarion Provides Corporate Update on Nociscan AI Technology MilestonesSeptember 12, 2024 | finanznachrichten.deAclarion Provides Corporate Update on Nociscan AI Technology MilestonesSeptember 12, 2024 | globenewswire.comAclarion, Inc.: Aclarion Announces Completion of First Nociscan Exams in LIFEHAB TrialSeptember 10, 2024 | finanznachrichten.deAclarion Announces Completion of First Nociscan Exams in LIFEHAB TrialSeptember 10, 2024 | globenewswire.comAclarion Added to PRISM Emerging Medical Devices IndexSeptember 6, 2024 | globenewswire.comAclarion Launches Surgeon Partnership to Apply Nociscan’s AI Technology to Personal Injury and Workers Compensation MarketSeptember 5, 2024 | markets.businessinsider.comAclarion Launches Surgeon Partnership to Apply Nociscan's AI Technology to Personal Injury and Workers Compensation MarketSeptember 5, 2024 | globenewswire.comAclarion Launches Second Clinical Utility and Economic (CLUE) Trial Site With First Surgeon in New JerseyAugust 29, 2024 | globenewswire.comMicron To $140? Here Are 10 Top Analyst Forecasts For MondayAugust 28, 2024 | msn.comMaxim Group Remains a Buy on Aclarion, Inc. (ACON)August 23, 2024 | markets.businessinsider.comAclarion Launches the Clinical Utility and Economic (CLUE) Trial to Quantify How Often Nociscan's AI Generated Biomarker Data Changes Surgical Treatment PlansAugust 21, 2024 | globenewswire.comAclarion to Present at August 20th Virtual Investor Summit Microcap EventAugust 15, 2024 | globenewswire.comAclarion Announces First Commercial Agreement in MichiganAugust 14, 2024 | globenewswire.comAclarion Hits Another Key Milestone by Adding Vitality - Third Major Payer to Cover Nociscan in Greater UKAugust 13, 2024 | globenewswire.comAscendiant Capital Initiates Coverage of Aclarion (ACON) with Buy RecommendationJuly 31, 2024 | msn.comAnalysts Offer Insights on Healthcare Companies: Aclarion, Inc. (ACON), Edwards Lifesciences (EW) and Sanofi (OtherSNYNF)July 29, 2024 | markets.businessinsider.comAclarion Achieves Milestone With Key Second Payer Coverage of Nociscan by Aviva Throughout Greater London, UKJuly 9, 2024 | globenewswire.comAclarion Announces Initial Payer Coverage of Nociscan by AXA Throughout Greater London, UKJune 26, 2024 | globenewswire.comAclarion Expands Commercial Engagement With The London Clinic to Grow Access to Nociscan Throughout Greater LondonJune 25, 2024 | globenewswire.comACON Stock Earnings: Aclarion Reported Results for Q1 2024May 16, 2024 | msn.comAclarion's Nociscan Solution to Play Key Role in Groundbreaking LIFEHAB Trial Evaluating the Diagnosis and Treatment of Chronic Low Back PainApril 25, 2024 | globenewswire.comAclarion to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024April 23, 2024 | finance.yahoo.com Get Aclarion News Delivered to You Automatically Sign up to receive the latest news and ratings for ACON and its competitors with MarketBeat's FREE daily newsletter. Email Address ACON Media Mentions By Week ACON Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ACON News Sentiment▼0.000.60▲Average Medical News Sentiment ACON News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ACON Articles This Week▼21▲ACON Articles Average Week Get Aclarion News Delivered to You Automatically Sign up to receive the latest news and ratings for ACON and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Kindly MD News Today BioNexus Gene Lab News Today Ontrak News Today SunLink Health Systems News Today Vsee Health News Today ATI Physical Therapy News Today Agape ATP News Today NewGenIvf Group News Today IMAC News Today Better Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ACON) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aclarion, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aclarion With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ACON Stock Alerts